Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

California

Cancer surgery and procedure trials in California

219 cancer surgery and procedure studies are recruiting participants at sites in 104 cities across California as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse California by city

Cities with the most studies recruiting right now.

Every California city with a recruiting study

By research area: Lymphoma (77), Prostate Cancer (45), Breast Cancer (41), Lung Cancer (34), Pancreatic Cancer (12), Melanoma (10).

Duarte (93), Los Angeles (71), San Francisco (61), Sacramento (54), Irvine (45), Orange (35), Palo Alto (28), La Jolla (27), Santa Rosa (25), Fremont (24), Vallejo (24), Modesto (23), Oakland (23), Roseville (22), San Diego (22), Loma Linda (21), Beverly Hills (18), Long Beach (18), San Jose (18), Torrance (18), Walnut Creek (18), Fresno (16), San Rafael (16), San Leandro (14), Santa Clara (14), South San Francisco (14), Dublin (13), Berkeley (12), San Mateo (12), Arroyo Grande (11), Carmichael (10), Elk Grove (10), Lancaster (10), Rocklin (10), Stockton (10), Sunnyvale (10), Upland (10), Woodland (10), Burbank (9), Pasadena (9), San Luis Obispo (9), South Pasadena (9), Tarzana (9), Anaheim (8), Auburn (8), Bellflower (8), Fontana (8), Newport Beach (8), Santa Cruz (8), Santa Maria (8), Madera (7), Ontario (7), Riverside (7), Santa Barbara (7), Bakersfield (6), Baldwin Park (6), Burlingame (6), Cameron Park (6), Downey (6), Harbor City (6), Marysville (6), Panorama City (6), Rancho Mirage (6), San Marcos (6), Stanford (6), Vacaville (6), Woodland Hills (6), Antioch (5), Chico (5), Mountain View (5), Napa (5), Richmond (5), Santa Monica (5), Truckee (5), Costa Mesa (4), Encinitas (4), Huntington Beach (4), Merced (4), Palm Springs (4), Yorba Linda (4), Corona (3), Davis (3), Emeryville (3), Laguna Hills (3), Redwood City (3), Salinas (3), Alhambra (2), Castro Valley (2), Clovis (2), Marina del Rey (2), Martinez (2), Novato (2), Pleasanton (2), Rancho Cordova (2), Rohnert Park (2), St. Helena (2), Arcadia (1), Fullerton (1), Los Alamitos (1), Mather (1), Oceanside (1), Visalia (1), West Los Angeles (1), Whittier (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in California

Basic details from each study's public record (the 12 most recently updated of 219). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

    • Phase 1
    • Ages 12 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Los Angeles · Newport Beach
    Registry record
    NCT05372640 · updated
  2. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Arroyo Grande · Carmichael · Elk Grove · and 10 more U.S. locations
    Registry record
    NCT05564377 · updated
  3. Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

    • Phase 2
    • Ages 35 and older
    • Female participants
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Duarte
    Registry record
    NCT05941520 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in California on ClinicalTrials.gov.

Lung cancer: recently updated in California

  1. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Beverly Hills · Los Angeles · San Francisco · and 1 more U.S. location
    Registry record
    NCT04665739 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in California on ClinicalTrials.gov.

Prostate cancer: recently updated in California

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Los Angeles · Newport Beach
    Registry record
    NCT03866382 · updated
  2. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Los Angeles
    Registry record
    NCT05691465 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in California on ClinicalTrials.gov.

Melanoma: recently updated in California

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Beverly Hills · Irvine · Los Angeles · and 1 more U.S. location
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in California on ClinicalTrials.gov.

Lymphoma: recently updated in California

  1. Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Duarte · Irvine · La Jolla · and 1 more U.S. location
    Registry record
    NCT03739814 · updated
  2. Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Duarte · Sacramento
    Registry record
    NCT05272384 · updated
  3. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

    • Phase 2
    • Up to 365 days
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Loma Linda · Long Beach · Oakland · and 3 more U.S. locations
    Registry record
    NCT06317662 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in California on ClinicalTrials.gov.

Pancreatic cancer: recently updated in California

  1. APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Berkeley · Fremont · Modesto · and 9 more U.S. locations
    Registry record
    NCT04858334 · updated
  2. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Duarte · Irvine · Orange · and 1 more U.S. location
    Registry record
    NCT05372614 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in California on ClinicalTrials.gov.

Ask about studies in California

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call